Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hepatitis A Virus Vaccines
New hepatitis A virus vaccines study findings have been published by scientists at Institute for Viral Disease Control and Prevention
June 11th, 2008
New research, 'Efficient neutralizing activity of cocktailed recombinant human antibodies against hepatitis A virus infection in vitro and in vivo,' is the subject of a report. According to recent research from Beijing, People's Republic of China, "Hepatitis A virus (HAV) is the major pathogen responsible for acute infectious hepatitis A, a disease that is prevalent worldwide. Although HAV immunization effectively prevents infection, primary immunizations must be administered at least 2 weeks prior to HAV exposure." "In contrast, passive immunization with pooled human immunoglobulin (Ig) can provide immediate and rapid protection from HAV infection. Because the use of...
Source: Vaccine Weekly (2008-06-11)
|
